These differences suggest that ESCC patients may have higher instability of CSMD1 or, alternatively, that the diverse methods used across these studies (e.g., SNP vs. CGH arrays) may have influenced these variations [6]. The gene discussed is CSMD1; the disease is esophageal squamous cell carcinoma.